Showing results (921-930 of 1,068) with videos related to

Sort By:
Pageof 107
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 27, 2016
Merkel cell carcinoma: value of sentinel lymph-node status and adjuvant radiation therapyA Servy, E Maubec, P E Sugier, et al.
JCO Precision Oncology|November 10, 2022
Non-V600E/K BRAF Mutations in Metastatic Melanoma: Molecular Description, Frequency, and Effectiveness of Targeted Therapy in a Large National CohortManon Girod, Stéphane Dalle, Laurent Mortier, et al.
Mabs|March 10, 2015
Dose - response relationship of bevacizumab in hereditary hemorrhagic telangiectasiaNicolas Azzopardi, Sophie Dupuis-Girod, David Ternant, et al.
Human Genetics|January 26, 2020
A new mutational hotspot in the SKI gene in the context of MFS/TAA molecular diagnosisPauline Arnaud, Caroline Racine, Nadine Hanna, et al.
Pathogens (Basel, Switzerland)|March 27, 2024
The Re-Emergence of Rift Valley Fever in Mananjary District, Madagascar in 2021: A Call for ActionAina Nirina Harimanana, Soa Fy Andriamandimby, Dany Bakoly Ranoaritiana, et al.
In Silico Biology|April 20, 2004
IMGT-ONTOLOGY for immunogenetics and immunoinformaticsMarie-Paule Lefranc, Véronique Giudicelli, Chantal Ginestoux, et al.
The Lancet. Respiratory Medicine|June 21, 2014
Effect of telomere length on survival in patients with idiopathic pulmonary fibrosis: an observational cohort study with independent validationBridget D Stuart, Joyce S Lee, Julia Kozlitina, et al.
Plos One|October 6, 2017
Pulmonary hypertension subtypes associated with hereditary haemorrhagic telangiectasia: Haemodynamic profiles and survival probabilitySabine Revuz, Evelyne Decullier, Isabelle Ginon, et al.
European Journal of Medical Genetics|August 8, 2022
European Reference Network for Rare Vascular Diseases (VASCERN): When and how to use intravenous bevacizumab in Hereditary Haemorrhagic Telangiectasia (HHT)?Sophie Dupuis-Girod, Claire L Shovlin, Anette D Kjeldsen, et al.
Oncotarget|June 23, 2016
Identification of new candidate therapeutic target genes in head and neck squamous cell carcinomasMarie-Paule Sablin, Coraline Dubot, Jerzy Klijanienko, et al.
Pageof 107